Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04810624 · ClinicalTrials.gov registry record · NA
Relapse Prevention and Changing Habits in Anorexia Nervosa
A NA study, sponsored by New York State Psychiatric Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04810624: Recruiting NA study, sponsored by New York State Psychiatric Institute.
NCT04810624 is a NA study that is actively recruiting participants, run by New York State Psychiatric Institute. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04810624, a NA study, is actively recruiting participants, sponsored by New York State Psychiatric Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Primary Outcome
Measured via rate of weight loss (in lbs) following discharge from inpatient unit
Interventions
- BEHAVIORAL Relapse Prevention and Changing Habits (REACH+)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT04810624 shows while recruiting
NCT04810624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Relapse Prevention and Changing Habits (REACH+) is the first listed.
NCT04810624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04810624 about?
NCT04810624 is a clinical study titled "Relapse Prevention and Changing Habits in Anorexia Nervosa". This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes...
What is the current status of trial NCT04810624?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-21. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT04810624?
The interventions under investigation include: Relapse Prevention and Changing Habits (REACH+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04810624?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04810624's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI